SWOG clinical trial number
SWOG-8744
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Multiple Myeloma
Closed
Phase
Accrual
27%
Abbreviated Title
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Multiple Myeloma
Activated
08/01/1988
Closed
11/15/1990